2022-02-012023-01-312023-01-31false09955144Rejuiced Liquids Limited2023-10-05iso4217:GBPxbrli:pure099551442022-02-01099551442023-01-31099551442022-02-012023-01-31099551442021-02-01099551442022-01-31099551442021-02-012022-01-3109955144bus:SmallEntities2022-02-012023-01-3109955144bus:AuditExempt-NoAccountantsReport2022-02-012023-01-3109955144bus:FullAccounts2022-02-012023-01-3109955144bus:PrivateLimitedCompanyLtd2022-02-012023-01-3109955144core:WithinOneYear2023-01-3109955144core:AfterOneYear2023-01-3109955144core:WithinOneYear2022-01-3109955144core:AfterOneYear2022-01-3109955144core:ShareCapital2023-01-3109955144core:SharePremium2023-01-3109955144core:RevaluationReserve2023-01-3109955144core:OtherReservesSubtotal2023-01-3109955144core:RetainedEarningsAccumulatedLosses2023-01-3109955144core:ShareCapital2022-01-3109955144core:SharePremium2022-01-3109955144core:RevaluationReserve2022-01-3109955144core:OtherReservesSubtotal2022-01-3109955144core:RetainedEarningsAccumulatedLosses2022-01-3109955144core:LandBuildings2023-01-3109955144core:PlantMachinery2023-01-3109955144core:Vehicles2023-01-3109955144core:FurnitureFittings2023-01-3109955144core:OfficeEquipment2023-01-3109955144core:NetGoodwill2023-01-3109955144core:IntangibleAssetsOtherThanGoodwill2023-01-3109955144core:ListedExchangeTraded2023-01-3109955144core:UnlistedNon-exchangeTraded2023-01-3109955144core:LandBuildings2022-01-3109955144core:PlantMachinery2022-01-3109955144core:Vehicles2022-01-3109955144core:FurnitureFittings2022-01-3109955144core:OfficeEquipment2022-01-3109955144core:NetGoodwill2022-01-3109955144core:IntangibleAssetsOtherThanGoodwill2022-01-3109955144core:ListedExchangeTraded2022-01-3109955144core:UnlistedNon-exchangeTraded2022-01-3109955144core:LandBuildings2022-02-012023-01-3109955144core:PlantMachinery2022-02-012023-01-3109955144core:Vehicles2022-02-012023-01-3109955144core:FurnitureFittings2022-02-012023-01-3109955144core:OfficeEquipment2022-02-012023-01-3109955144core:NetGoodwill2022-02-012023-01-3109955144core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3109955144core:ListedExchangeTraded2022-02-012023-01-3109955144core:UnlistedNon-exchangeTraded2022-02-012023-01-3109955144core:MoreThanFiveYears2022-02-012023-01-3109955144core:Non-currentFinancialInstruments2023-01-3109955144core:Non-currentFinancialInstruments2022-01-3109955144dpl:CostSales2022-02-012023-01-3109955144dpl:DistributionCosts2022-02-012023-01-3109955144dpl:AdministrativeExpenses2022-02-012023-01-3109955144core:LandBuildings2022-02-012023-01-3109955144core:PlantMachinery2022-02-012023-01-3109955144core:Vehicles2022-02-012023-01-3109955144core:FurnitureFittings2022-02-012023-01-3109955144core:OfficeEquipment2022-02-012023-01-3109955144core:NetGoodwill2022-02-012023-01-3109955144core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3109955144dpl:GroupUndertakings2022-02-012023-01-3109955144dpl:ParticipatingInterests2022-02-012023-01-3109955144dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3109955144core:ListedExchangeTraded2022-02-012023-01-3109955144dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3109955144core:UnlistedNon-exchangeTraded2022-02-012023-01-3109955144dpl:CostSales2021-02-012022-01-3109955144dpl:DistributionCosts2021-02-012022-01-3109955144dpl:AdministrativeExpenses2021-02-012022-01-3109955144core:LandBuildings2021-02-012022-01-3109955144core:PlantMachinery2021-02-012022-01-3109955144core:Vehicles2021-02-012022-01-3109955144core:FurnitureFittings2021-02-012022-01-3109955144core:OfficeEquipment2021-02-012022-01-3109955144core:NetGoodwill2021-02-012022-01-3109955144core:IntangibleAssetsOtherThanGoodwill2021-02-012022-01-3109955144dpl:GroupUndertakings2021-02-012022-01-3109955144dpl:ParticipatingInterests2021-02-012022-01-3109955144dpl:GroupUndertakingscore:ListedExchangeTraded2021-02-012022-01-3109955144core:ListedExchangeTraded2021-02-012022-01-3109955144dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-02-012022-01-3109955144core:UnlistedNon-exchangeTraded2021-02-012022-01-3109955144core:NetGoodwill2023-01-3109955144core:IntangibleAssetsOtherThanGoodwill2023-01-3109955144core:LandBuildings2023-01-3109955144core:PlantMachinery2023-01-3109955144core:Vehicles2023-01-3109955144core:FurnitureFittings2023-01-3109955144core:OfficeEquipment2023-01-3109955144core:AfterOneYear2023-01-3109955144core:WithinOneYear2023-01-3109955144core:ListedExchangeTraded2023-01-3109955144core:UnlistedNon-exchangeTraded2023-01-3109955144core:ShareCapital2023-01-3109955144core:SharePremium2023-01-3109955144core:RevaluationReserve2023-01-3109955144core:OtherReservesSubtotal2023-01-3109955144core:RetainedEarningsAccumulatedLosses2023-01-3109955144core:NetGoodwill2022-01-3109955144core:IntangibleAssetsOtherThanGoodwill2022-01-3109955144core:LandBuildings2022-01-3109955144core:PlantMachinery2022-01-3109955144core:Vehicles2022-01-3109955144core:FurnitureFittings2022-01-3109955144core:OfficeEquipment2022-01-3109955144core:AfterOneYear2022-01-3109955144core:WithinOneYear2022-01-3109955144core:ListedExchangeTraded2022-01-3109955144core:UnlistedNon-exchangeTraded2022-01-3109955144core:ShareCapital2022-01-3109955144core:SharePremium2022-01-3109955144core:RevaluationReserve2022-01-3109955144core:OtherReservesSubtotal2022-01-3109955144core:RetainedEarningsAccumulatedLosses2022-01-3109955144core:NetGoodwill2021-02-0109955144core:IntangibleAssetsOtherThanGoodwill2021-02-0109955144core:LandBuildings2021-02-0109955144core:PlantMachinery2021-02-0109955144core:Vehicles2021-02-0109955144core:FurnitureFittings2021-02-0109955144core:OfficeEquipment2021-02-0109955144core:AfterOneYear2021-02-0109955144core:WithinOneYear2021-02-0109955144core:ListedExchangeTraded2021-02-0109955144core:UnlistedNon-exchangeTraded2021-02-0109955144core:ShareCapital2021-02-0109955144core:SharePremium2021-02-0109955144core:RevaluationReserve2021-02-0109955144core:OtherReservesSubtotal2021-02-0109955144core:RetainedEarningsAccumulatedLosses2021-02-0109955144core:AfterOneYear2022-02-012023-01-3109955144core:WithinOneYear2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:CostValuation2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-012023-01-3109955144core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3109955144core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3109955144core:Non-currentFinancialInstrumentscore:CostValuation2022-01-3109955144core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-01-3109955144core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-01-3109955144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-01-3109955144core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-01-3109955144core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-01-3109955144core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-01-3109955144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-01-3109955144core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-01-3109955144bus:Director12022-02-012023-01-3109955144bus:Director22022-02-012023-01-3109955144core:FurnitureFittingsToolsEquipment2022-01-3109955144core:FurnitureFittingsToolsEquipment2023-01-3109955144core:FurnitureFittingsToolsEquipment2022-02-012023-01-31

Rejuiced Liquids Limited

Registered Number
09955144
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2023

Rejuiced Liquids Limited
Company Information
for the year from 1 February 2022 to 31 January 2023

Directors

Mr A Wedd
Mrs L Wedd

Registered Address

10 Western Road
Romford
RM1 3JT

Registered Number

09955144 (England and Wales)
Rejuiced Liquids Limited
Balance Sheet as at
31 January 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets748,00056,400
Tangible assets8130,027162,534
178,027218,934
Current assets
Stocks1150,23094,380
Debtors1219,45315,504
Cash at bank and on hand294,203490,325
363,886600,209
Creditors amounts falling due within one year13(97,084)(203,109)
Net current assets (liabilities)266,802397,100
Total assets less current liabilities444,829616,034
Provisions for liabilities14(19,205)(24,174)
Net assets425,624591,860
Capital and reserves
Called up share capital100100
Profit and loss account425,524591,760
Shareholders' funds425,624591,860
The financial statements were approved and authorised for issue by the Board of Directors on 5 October 2023, and are signed on its behalf by:
Mr A Wedd
Director
Registered Company No. 09955144
Rejuiced Liquids Limited
Notes to the Financial Statements
for the year ended 31 January 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principle activity of the company continued to be that of the production of e-liquids for vaping purposes.
4.Basis of measurement used in financial statements
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
5.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Fixtures and fittings20
Vehicles20
Intangible assets policy
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years. For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually,or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.
Stocks policy
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Government grants and other government assistance policy
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
Leases policy
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease. At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases of 2023 - £42,000 (2022 - £94,167).
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
6.Employee information

20232022
Average number of employees during the year99
7.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 February 2284,00084,000
At 31 January 2384,00084,000
Amortisation and impairment
At 01 February 2227,60027,600
Charge for year8,4008,400
At 31 January 2336,00036,000
Net book value
At 31 January 2348,00048,000
At 31 January 2256,40056,400
8.Property, plant and equipment

Vehicles

Fixtures & fittings

Total

£££
Cost or valuation
At 01 February 22156,038246,394402,432
At 31 January 23156,038246,394402,432
Depreciation and impairment
At 01 February 2280,213159,685239,898
Charge for year15,16517,34232,507
At 31 January 2395,378177,027272,405
Net book value
At 31 January 2360,66069,367130,027
At 31 January 2275,82586,709162,534
9.Directors advances, credits and guarantees
At the year end the company owed the directors £497 (2022 - £3,458) by way of their directors current accounts.
10.Dividends proposed and payable

2023

2022

££
Dividends Paid326,000373,500
Total326,000373,500
The dividends shown above were paid in the year in respect of shares held by the company’s directors.
11.Stocks

2023

2022

££
Raw materials and consumables50,23094,380
Total50,23094,380
12.Debtors

2023

2022

££
Other debtors2,502-
Prepayments and accrued income16,95115,504
Total19,45315,504
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
13.Creditors within one year

2023

2022

££
Trade creditors / trade payables10,60428,690
Taxation and social security82,864118,590
Finance lease and HP contracts-49,666
Other creditors1,5314,109
Accrued liabilities and deferred income2,0852,054
Total97,084203,109
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. The hire purchase creditor due both within and after one year is secured against the asset to which it relates.
14.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)19,20524,174
Total19,20524,174